| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |